28Aug 2018

TUM?FACTION BUCCALE R?V?LATRICE D?UN MY?LOME MULTIPLEA PROPOS D?UN CAS CLINIQUE.

  • Service de stomatologie et de chirurgie faciale CHN (Mauritanie).
  • centre national d?oncologie de Nouakchott (Mauritanie).
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Multiple myeloma is a malignant disease characterized by multifocal proliferation of atypical plasma cells.that usually occurs between 50 and 80 years of age. His favorite seat is mainly vertebrae, skull, pelvis, ribs, humerus and femur. Myeloma ranks 17th among the leading causes of cancer deaths in the world by WHO. The case presented is that of a 40-year-old patient referred to a specialized consultation of stomatology and facial surgery at the National Hospital Center of Nouakchott (Mauritania) for the management of multiple maxillomandibular tumefactions, initially considered to be infectious origin. Samples made on the lesions showed that it was multiple myeloma. This observation illustrates the diagnostic difficulties of oral neoplasia, which was initially considered to be a benign gum lesion.


  1. Meet K, Parwinder K, Rakhi G, Shally G, Simranjit S. Mandibular plasmacytoma of jaw ? A case report. J ClinDiagnRes 2014.
  2. Bourjat P, Kahn JL, Braun J. Imagerie des plasmocytomes solitaires maxillo-mandibulaires. J Radiol1999; 80: 859-62.
  3. Dieye M, Qu?nel P, Goria S, Blateau A, Colonna M, Azaloux H. ?tude de la r?partition spatiale des cancers possiblement li?s ? la pollution des sols par les pesticides organochlor?s, en Martinique (27 p). Institut de veille sanitaire 2009.
  4. Epstein JB, Voss NJ, Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol 1984.
  5. Pisano JJ, Coupland R, Chen SY, Miller AS. Plasmacytoma of the oral cavity and jaws: a clinicopathologic study of 13 cases. Oral Surg Oral Med Oral Pathol Oral RadiolEndod1997;83:265-71.
  6. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842-54.
  7. Claudia Araceli Torres Urbina1, AguedaMarisolArellano Flores2, Jos? Luis Vazquez Salvador1, Arlette Araceli Barbosa Ibarra3, Roc?o Gloria Fernandez Lopez2,
  8. Beatr?zCatalinaAldape Barrios4, Med buccalechirbuccale2010;16:183-188.
  9. CHIRAZ HAFSA1, TOUHAMI BEN ALAYA1,2, SOULEF KRIAA1, HAYKEL DEBBABI1, MOHAMED BEN KHELIFA3, MONDHER GOLLI1, HABIB HAMDI3, AMOR GANNOUNI1. M?decine buccale chirurgie buccale VOL. 13, N? 4 ,2007.
  10. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blad? J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J. International staging system for multiple myeloma. J ClinOncol2005;23:3412-20.
  11. Owotade F, Ugboko V, Ajike S, Salawu L, Amusa Y, Omole M. Head and neck manifestations of myeloma in Nigerians. Int J Oral MaxillofacSurg2005;34:761-5 .
  12. Jennifer Even1, Capucine LeGoubey1, Yannick Sudrat1, Laurent Devoize,3Med BuccaleChirBuccale 2010,3;19:113-117 .
  13. 13- D. Smith et K. Yong, ? Multiple myeloma ?, BMJ, vol. 346, no jun26 2, p. f3863‐f3863, juin 2013

[Veten. Mohamed, Ould Ely S.O and Ekhtelbenina.Zein. (2018); TUM?FACTION BUCCALE R?V?LATRICE D?UN MY?LOME MULTIPLEA PROPOS D?UN CAS CLINIQUE. Int. J. of Adv. Res. 6 (Aug). 1012-1016] (ISSN 2320-5407). www.journalijar.com


Veten Mohamed


DOI:


Article DOI: 10.21474/IJAR01/7605      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7605